Literature DB >> 19301949

Immunogenic properties of recombinant ectodomain of Newcastle disease virus hemagglutinin-neuraminidase protein expressed in Escherichia coli.

S K Wong1, W S Tan, A R Omar, C S Tan, K Yusoff.   

Abstract

Hemagglutinin-neuraminidase (HN) protein of Newcastle disease virus (NDV) plays a vital role in the viral infectivity, host immunity, and disease diagnosis. A portion of the HN gene encoding the ectodomain (nt 142-1739) was cloned and expressed in Escherichia coli yielding an insoluble HN protein and a soluble NusA-HN protein containing N-utilization substance A (NusA) fusion component. Both recombinant proteins were purified and used for immunization of chickens. The recombinant HN protein induced higher antibody titers as compared to the recombinant NusA-HN protein. These antibodies were able to react in immunoblot analysis with the corresponding recombinant proteins as well as with the HN protein of NDV.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19301949     DOI: 10.4149/av_2009_01_35

Source DB:  PubMed          Journal:  Acta Virol        ISSN: 0001-723X            Impact factor:   1.162


  3 in total

1.  Designing a Novel Recombinant HN Protein with Multi Neutralizing Antigenic Sites and Auto Tag Removal Ability Based on NDV-VIIj for Diagnosis and Vaccination Application.

Authors:  Vafa Mayahi; Majid Esmaelizad; Naser Harzandi
Journal:  Indian J Microbiol       Date:  2018-04-25       Impact factor: 2.461

2.  Comprehensive Analysis and Characterization of Linear Antigenic Domains on HN Protein from Genotype VII Newcastle Disease Virus Using Yeast Surface Display System.

Authors:  Tao Li; Gaoling Wang; Bingtian Shi; Peixin Liu; Wei Si; Bin Wang; Li Jiang; Lunjiang Zhou; Jinsheng Xiu; Henggui Liu
Journal:  PLoS One       Date:  2015-06-29       Impact factor: 3.240

3.  Immunogenicity of the Multi-Epitopic Recombinant Glycoproteins of Newcastle Disease Virus: Implications for the Serodiagnosis Applications.

Authors:  Mohammad Javad Motamedi; Shahla Shahsavandi; Jafar Amani; Rouhollah Kazemi; Somayeh Takrim; Mahyat Jafari; Ali-Hatef Salmanian
Journal:  Iran J Biotechnol       Date:  2018-12-12       Impact factor: 1.671

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.